Objective: We investigated the quality of randomized controlled trials (RCTs) that included direct comparisons of psychotherapy for adults with an eating disorder (ED).
. National treatment guidelines often rely on the results of RCTs to inform clinicians' interventions for EDs. Despite the influence that RCTs have in the development of treatment guidelines, researchers and clinicians often do not take into account the methodological quality of RCTs when interpreting treatment effects (Moher et al., 1998) . This is important because research indicates that study quality may be negatively related to the magnitude of psychotherapy effect sizes for other mental disorders (Cuijpers, van Straten, Bohlmeijer, Hollon, & Andersson, 2010) .
Researchers argue that RCT designs yield valid results of treatment efficacy because they control for unmeasured confounds (Higgins & Green, 2011) . Despite this, RCTs of psychotherapy are still susceptible to methodological flaws that threaten internal validity such as not analyzing the intent-to-treat sample, using outcome measures that are not validated, and having less than adequate sample sizes that reduce statistical power. These issues, along with others, can lead to misleading findings because the magnitude of the treatment effects can be affected by poor study quality (Jüni, Altman, & Egger, 2001 ).
Researchers have discussed how to objectively define and rate study quality. Specific measures and guidelines such as the Cochrane Risk of Bias tool Watson et al. (2017) found that the quality of 96 RCTs of prevention programs for EDs was significantly and positively associated with publication year. However, the Cochrane tool and the CONSORT guidelines do not address quality issues specific to psychotherapy trials, such as length of follow-up, the training or supervision of therapists, adherence to treatment manuals, or consideration of therapist and/ or site effects.
In 2004, a subcommittee of the American Psychiatric Association
Committee on Research developed a rating scale to assess the methodological and reporting quality of psychotherapy RCTs. This subcommittee established the Randomized Controlled Trials of Psychotherapy Quality Rating Scale (RCT-PQRS; Kocsis et al., 2010) as a new standard for the design and execution of psychotherapy RCTs. Since its development, researchers have used the RCT-PQRS used to evaluate the quality of RCTs of psychotherapy for depression (Thoma et al., 2012) and anxiety (Keefe, McCarthy, Dinger, Zilcha-Mano, & Barber, 2014) . No such evaluation has been conducted for RCTs of psychotherapy for EDs.
| Study quality and effect size
Meta-analysis has emerged an important method for aggregating effect sizes and to evaluate the efficacy of treatments (Egger, Smith, Schneider, & Minder, 1997) . Past meta-analyses found that the quality of RCTs is related to the magnitude of reported effect sizes. For example, Cuijpers et al. (2010) conducted a meta-analysis examining the efficacy of psychotherapy for depression while taking study quality into account. Results indicated that higher quality studies had smaller effect sizes (when compared with lower quality studies), and as a result, the overall effect sizes for psychotherapy for depression may be overestimated (Cuijpers et al., 2010) .
Two recent meta-analyses (Grenon et al., 2017; press) of RCTs demonstrated that psychotherapy for EDs is effective. Yager et al., 2012) , we believe that it is essential to examine whether the quality of an RCT is related to the magnitude of effect sizes.
| Study quality in different contexts and groups
Several factors and contexts might be associated with study quality to affect the precision with which one can interpret effect sizes.
First, psychotherapy for EDs may be delivered in a group and individual format, and both modalities are now included in some national treatment guidelines and recommendations for EDs (Yager et al., 2012) . Previous research demonstrated that the study quality of group and individual RCTs for both depression (Cuijpers et al., 2010) and generalized anxiety (Cuijpers et al., 2014) are equivalent; however, these studies did not control for year of publication.
Recall that publication year is positively associated with higher study quality (Kocsis et al., 2010; Watson et al., 2017) and that higher study quality is related to lower effect sizes (Cuijpers et al., 2010) .
Second, treatment guidelines and recommendations are specific to ED diagnosis such that the treatment recommendations for bulimia nervosa (BN) may be different than those for binge-eating disorder (BED), for example. A recent meta-analysis suggested that the average effect size of group treatment versus other active treatments for BED is higher than for BN (Grenon et al., 2017) .
BN was introduced as an ED diagnosis in the DSM-III (APA, 1980), whereas BED was introduced as research criteria for EDs in the DSM-IV (American Psychiatric Association, 1994). As a result, the average year of publication for BN trials (1992) is much earlier than the average year of BED trials (2002; see Table 1 ). Treatment for anorexia nervosa (AN) typically includes a variety of interventions making the effects of group or individual psychotherapy alone impossible to isolate. Further, there are few RCTs of psychotherapy for AN.
Third, some might argue that RCTs published in journals with higher impact factors (IFs) might be better quality than RCTs published in journals with lower IFs. The IF was established in the 1960s by Eugene Garfield as a way to assess the importance or prominence of a journal by a calculation that reflects the average number of citations of studies recently published (Garfield, 2006) . Some authors express skepticism about how the IF is calculated and whether it actually represents the quality of studies published in a journal (Baum, 2011; Misteli, 2013; Seglen, 1997) . The IFs of journals have steadily increased over time independent of their initial IF (Althouse, West, Bergstrom, & Bergstrom, 2008) . Some have attributed this increase in IF to the growth of research in many fields, and thus an increase in the number of references in each manuscript; easy access to literature via the internet, which has led to an increased number of citations; the rising value of citations for individual authors; and a tendency to cite work found within the journal in which authors hope to publish (Althouse et al., 2008) . Alternatively, one could argue that the increase of a journal's IF could be due to the increasing quality of studies published over time in that journal that drives more citations. Due to the more recent development of quality checklists and journal editors requiring that authors adhere to publishing standards, we hypothesized that the quality of RCTs of psychotherapy for EDs has significantly improved over time. On the basis of the findings from Cuijpers et al. (2010) , we hypothesize that study quality will be significantly and negatively related to effect size, with higher quality trials reporting smaller effect sizes than lower quality trials. In order to help interpret the effects of psychotherapy more precisely, we explore whether there is a significant difference in study quality between group and individual psychotherapy RCTs, and between BED and BN trials, while controlling for publication year. We also expect that study quality will mediate the significant and positive relationship between publication year and journal IF. To our knowledge, this is the first study to assess these associations. psychotherapy RCTs for adults with an ED. Full methodology is provided in two previous meta-analyses (Grenon et al., 2017; Grenon et al., in press ).
| Inclusion and exclusion criteria
The following inclusion and exclusion criteria were specified a priori.
To be included, studies had to ( 
| Study quality
Quality was assessed using the RCT-PQRS (Kocsis et al., 2010) , a 25-item standardized scale that is divided into six domains: (a) description of participants; (b) definition and delivery of treatment; (c) outcome measures; (d) data analysis; (e) treatment assignment; and (f) overall study quality. The scale yields a 24-item total score and a 1-item omnibus rating scale.
Items 1 through 24 were scored as 0, 1, or 2. A score of 0 was given for poor execution and description of the item. A score of 1 was given if the item was moderately described and executed, poorly described but well executed, or well described but poorly executed. A score of 2 was given for well described and executed items. The total quality score is the sum of Items 1 through 24 and ranges from 0 to 48. Gerber et al. (2011) proposed that a score of 24 or higher indicated an "average" quality study. Item 25 of the RCT-PQRS is an omnibus quality rating from 1 (exceptionally poor) to 7 (exceptionally good) of the overall quality of the study (Gerber et al., 2011) . selected studies (57%) to assess reliability specific to the current study's ratings. Interrater reliability was excellent for both the total score (ICC = 0.98) and the omnibus rating (ICC = 0.93). In the current study, Cronbach's alpha was 0.82 for the total score, and the correlation between total quality score and the omnibus rating was r = 0.97.
Given the high positive correlation between the total quality score and the omnibus score, we chose to only report analyses using the total quality score. The RCT-PQRS scores from other studies to which we compared our ratings were also reliably rated as reported in those studies (Keefe et al., 2014; Thoma et al., 2012) .
| Effect sizes
Between group (psychotherapy vs wait-list) effect sizes for continuous primary outcomes at post treatment were extracted from a previously published meta-analysis (Grenon et al., in press ). The effect sizes for frequency of binge eating and/or purging and ED psychopathology were computed using Hedge's g (standardized mean difference). All effect size calculations and analyses were computed in the Comprehensive Meta-Analysis program (Version 3; Borenstein, Hedges, Higgins, & Rothstein, 2005) . For full details on effect size calculations, see Grenon et al. (in press ).
| Impact factor
The IFs of journals that published the RCTs included in the current study were obtained through the Journal Citation Reports database (Journal Citation Reports Social Sciences Edition, 2016). Two IFs were obtained for each RCT: One IF for the journal in the year the study was published, and one IF for the journal 2 years after the study was published. The correlation between the two IF values was r(29) = 0.98 (p < 0.001). Thus, we chose to report only analyses using the IF for the journal 2 years after the study was published because it represents the impact of the journal for 2 years during which the study in question was included in the calculation. The Journal Citation
Reports database includes IFs dating from 1997 to present. IFs of studies that were published before 1997 were obtained via the Social Science Citation Index Journal Citation Reports (Garfield, 1985; 1986; 1987; 1988; 1990; 1991; 1992; 1993; 1994; 1995; 1996) .
One RCT (Allen, 1997 ) is a dissertation and was not included in any IF analysis. The IF for 2 years after the date of publication could not be calculated for the Fairburn et al. (2015) 
| Data analysis
To examine whether publication year and study quality were positively and significantly correlated, we conducted a regression between publication year and the total RCT-PQRS score. We conducted two separate Pearson correlations to examine whether study quality was associated with the magnitude of effect sizes for two separate primary To assess whether publication year predicted the magnitude of the IF, and whether study quality mediated this relationship, we tested a mediation model with year of publication as the predictor variable, IF as the outcome variable, and total RCT-PQRS score as the potential mediator. We ran this model using the PROCESS (Hayes, 2012) macro in SPSS. Finally, we compared the study quality of the 35 RCTs of psychotherapy for EDs to 120 RCTs of psychotherapy for depression (Thoma et al., 2012 ) and 14 RCTs of psychotherapy for anxiety (Keefe et al., 2014 ). An ANCOVA was conducted with type of RCT (ED, anxiety, or depression) as the independent variable, total RCT-PQRS score as the dependent variable, and publication year as a covariate. All analyses were conducted using IBM SPSS Statistics (IBM Corp, 2016).
3 | RESULTS
| Study quality
Thirty-five RCTs of direct comparisons of psychological treatments for EDs that were published between 1985 and 2015 (see Supporting Information for a complete reference list of included studies) were included in this study. Characteristics of the 35 RCTs can be seen in Table 1 .
The average omnibus rating of RCTs for EDs (Item 25) was 4.51 (SD = 1.22; range = 2 to 7). Twenty-eight RCTs (80%) received an omnibus rating of at least 4 (average quality; Gerber et al., 2011), but only two RCTs (5.7%) received an "exceptionally good" rating (omnibus rating of 7). The average total RCT-PQRS score (Items 1 to 24 summed) was 28.26 (SD = 7.04; range = 15 to 42). Twenty-seven RCTs (77%) received a total RCT-PQRS score of at least 24 indicating "average" quality, and only four (11%) received a total score of at least 40 indicating "exceptionally good" quality. The percentage of studies that scored 0 (not fulfilled), 1 (partially fulfilled), or 2 (fulfilled) for each item (1 to 24) can be seen in Figure 1 FIGURE 1 Percent of psychotherapy for eating disorders randomized controlled trials (RCTs) by item score (N = 35) on the RCT-Psychotherapy Quality Rating Scale. Items are rated from 0 to 2. Descriptions of items: Inclusion/exclusion criteria = diagnostic method and criteria for inclusion and exclusion. Diagnostic methodology = documentation or demonstration of reliability of diagnostic methodology. Comorbidities = Description of relevant comorbidities. Subjects screened = Description of numbers of subjects screened, included, and excluded. Described treatments = Treatment(s) (including control/comparison groups) are sufficiently described or referenced to allow for replication. Adherence = Method to demonstrate that treatment being studied is treatment being delivered (only satisfied by supervision if transcripts or tapes are explicitly reviewed). Therapist training = Therapist training and level of experience in the treatment(s) under investigation. Therapist supervision = Therapist supervision while treatment is being provided. Concurrent treatments = Description of concurrent treatments (e.g., medication) allowed and administered during course of study (if patients on medication are included, a rating of 2 requires full reporting of what medications were used; if patients on medications are excluded, this alone is sufficient for a rating of 2). Validated outcome measures = Validated outcome measure(s) (either established or newly standardized). A priori outcomes = Primary outcome measure(s) specified in advance (although does not need to be stated explicitly for a rating of 2). Blind raters = Outcome assessment by raters blinded to treatment group and with established reliability. Safety and adverse events = Discussion of safety and adverse events during study treatment(s). Adequate followup = Assessment of long-term posttermination outcome (should not be penalized for failure to follow comparison group if this is a wait-list or nontreatment group that is subsequently referred for active treatment). Intent to treat = Intent-to-treat method for data analysis involving primary outcome measure. 
| Publication year and study quality
As hypothesized, the total RCT-PQRS score was positively and statistically significantly related to publication year, r(33) = 0.66, p < 0.001; see path a in Figure 2 . The effect was large with more recent RCTs having higher study quality than older RCTs.
| Study quality and effect size
There was no statistically significant relationship between study quality and the effect sizes for frequency of binge eating and/or purging, r(11) = −0.44, p = 0.131. Similarly, there was no statistically significant relationship between study quality and the effect sizes for ED psychopathology, r(13) = −0.38, p = 0.161. However, both correlation coefficients were moderate in effect size, suggesting that these analyses were underpowered.
| Quality of group versus individual psychotherapy RCTs
There was no statistically significant difference in total RCT-PQRS scores, F (1, 33) = 0.105, p = 0.748, η p 2 = 0.003, between group psychotherapy RCTs (M = 28.39, SD = 6.81) and individual psychotherapy RCTs (M = 28.00, SD = 7.76), while controlling for publication year.
The effect of publication year as a control variable was significant with a large effect, F (1, 33) = 26.51, p < 0.001, η p 2 = 0.45.
| Quality of BN versus BED RCTs
There was no statistically significant difference in total RCT-PQRS 3.7 | Publication year and IF mediated by study quality
As mentioned above, there was a direct significant and positive relationship between publication year and study quality (Path a; Figure 2 ).
The direct relationship between study quality and IF was not statistically significant, and the effect was small, r ( 
| DISCUSSION
The overall goal of the current study was to evaluate the quality of apy for EDs were rated as "exceptional" in quality, and so there is considerable room for improvement. Many of the RCTs did not fulfill specific standards commonly expected from treatment trials. Nevertheless, the mean total RCT-PQRS (Kocsis et al., 2010) score of the RCTs of psychotherapy for EDs was similar to that obtained from 120 RCTs of cognitive behavioral therapy for depression (Thoma et al., 2012 ) and 14 RCTs of psychodynamic psychotherapy for anxiety (Keefe et al., 2014) . The results of the current study suggest that psychotherapy trials for EDs are of comparable quality and rigor as those found in other prominent areas of psychotherapy research.
We evaluated several factors that might be related to quality and therefore effect size. More recent RCTs of psychotherapy for EDs were more likely to have higher RCT-PQRS scores. Similar findings were reported from meta-analyses examining the quality RCTs of ED prevention (Watson et al., 2017) and of psychodynamic psychotherapy for a variety of mental illnesses (Kocsis et al., 2010) . A likely explanation for this positive relationship is the implementation of quality checklists that have been developed over the years. Journal editors are increasingly requiring that authors follow reporting guidelines such as CONSORT, and this has likely resulted in higher quality RCTs and/ or better reporting of RCTs (Schulz et al., 2010) . we examined whether the quality of an RCT was related to the magnitude of the effect size of primary outcomes at post treatment. We found nonstatistically significant correlations between study quality and effect sizes for primary outcome (frequency of binges and/or purges and ED psychopathology). However, these analyses were likely low in statistical power, and the correlations were negative and moderate in size, thus suggesting that lower quality may be related to higher effect sizes. This interpretation of our finding is consistent with reports by Cuijpers et al. (2010) for RCTs of psychotherapy for depression. This negative association between quality and effect size suggests that lower methodological quality may result in an overestimation of treatment effects.
We also evaluated contextual factors that may be related to study quality and, as a result, the magnitude of effects. and group psychotherapy studies and meta-analyses in informing national treatment guidelines for EDs (Yager et al., 2012) .
Second, given that treatment guidelines are written separately for each ED diagnosis, we assessed and described study quality by ED diagnosis. A simple inspection of the means in which publication year was not controlled indicated that trials for BED had higher mean study quality scores than trials for BN. This is not surprising because the average publication year of BED trials is 2002 whereas the average publication year of BN trials is 1992. The quality of RCTs of psychotherapy for BED and BN were not significantly different after publication year was controlled. Such a finding offers a more nuanced interpretation of the results of a previous meta-analysis that reported the effects of group psychotherapy versus another active treatment modality was significantly larger for BED than for BN (Grenon et al., 2017) . Recall that RCTs of BED are more recent, and therefore of higher quality leading to more conservative estimates of treatment effects. Hence, the difference in group treatment effect for BED versus BN is likely underestimated and larger than previously reported.
There was only one outpatient trial of psychotherapy for individuals diagnosed with AN (McIntosh et al., 2005) included in the current meta-analysis making it impossible to conduct analyses comparing AN, BN, and BED trials. While there is a great need for more RCTs on psychotherapy for AN, high treatment refusal rates, low recruitment numbers, and high dropout rates make completing such trials challenging (Halmi, 2008) .
Finally, we also conducted a mediation analysis to assess whether the relationship between publication year and IF was mediated by study quality. There was a significant indirect effect suggesting that higher study quality partially explained the positive association between publication year and IF. Critics have suggested that IFs can be inflated by journals that opt to publish studies that are likely to be highly cited, such as meta-analyses and systematic reviews (Misteli, 2013) . Some authors attribute IF inflation to an increase in the number of references in each manuscript over the years (Althouse et al., 2008) .
Our findings suggest that although these may be factors causing IF inflation over time, it is also possible that this increase in IFs is partly due to improved study quality in more recently published RCTs.
Readers should interpret this finding with some caution, and we encourage researchers to replicate these results in RCTs of psychotherapy for other disorders.
| Limitations and future directions
There are three notable limitations of the current study, which are true for all studies that asses the quality of RCTs. First, the methodological quality of a study cannot easily be distinguished from reporting quality. Ideally, authors should be able to fully report study methodology;
however, this is not the case given that many journal impose strict quality study. We hope that as more psychotherapy researchers use the RCT-PQRS, there will be more opportunities to compare findings, and establish norms for high, moderate, and low quality RCTs.
Finally, the inclusion/exclusion criteria that we employed for research evaluated in this study have the potential to affect the results we reported. First, non-RCTs were excluded, which likely lead to higher quality scores than had they been included. Second, RCTs that had participants with subthreshold ED diagnoses were excluded from our study. It is unknown how the inclusion of studies with these participants might affect quality scores. Third, we excluded studies in which participants received concurrent treatments including hospitalization and medications. Because of this, we excluded an RCT of the treatment of AN by Zipfel et al. (2014) , for example. We urge researchers to address questions of the effects of loosening or tightening inclusion and exclusion criteria so future authors of national treatment guidelines for EDs can determine whether findings from some studies should be considered when developing treatment recommendations.
| Conclusions and recommendations
The quality of psychotherapy RCTs for EDs has been continuously improving since 1985, likely due to the development and use of several quality checklists and reporting guidelines such as CONSORT (Schulz et al., 2010) . Despite this increase in quality, there remains room for improvement on many important quality criteria. Figure 1 presents the most common weaknesses found in psychotherapy trials for EDs. Six criteria were not fulfilled in over half of the included RCTs.
On the basis of the findings presented in Figure 1 , we recommend that ED treatment researchers report relevant comorbidities of all participants; have and report appropriate therapist supervision while treatment is being provided; blind outcome assessment raters to treatment groups and report the reliability among raters; use adequate sample sizes and report power calculations; consider and model therapist and/or site effects in analyses; and discuss and report safety and adverse events. Additionally, we recommend researchers to register all psychotherapy RCTs with organizations like clinicaltrials.gov; publish the RCT protocol, which outlines primary and secondary outcomes, hypotheses, and analyses prior to the start of the trial; use quality rating scales and checklists to help design studies (i.e., RCT-PQRS; Kocsis et al., 2010) ; and follow the CONSORT guidelines for reporting (Schulz et al., 2010) .
Given the correlations we found between study quality and effect size, and between year of publication and quality ratings in RCTs for EDs, we urge authors of meta-analyses to evaluate and report the quality of studies, or control for quality in their analyses, so that more accurate conclusions can be drawn regarding the magnitude of treatment effects. In addition, we suggest that authors of ED treatment guidelines consider the treatment effects reported in RCTs and meta-analyses for EDs within the context of the quality of the RCTs.
This would require a more detailed, comprehensive, and nuanced evaluation of the existing research to inform treatment guidelines.
